Monitor for any subsequent 13D conversion or additional accumulation by Fidelity. The 10.9% stake is significant for a micro-cap biotech and could signal conviction ahead of clinical catalysts.
GOSS drugs
GOSS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $9.77entry
- T+1 · 8d ago +8.96%α +6.59% · $10.65
- T+5 · 4d ago +12.28%α +9.69% · $10.97
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) disclosed a 10.9% passive stake in Gossamer Bio via Schedule 13G, with 667,465 shares held as of October 30, 2026. The stake is held through Fidelity Management & Research Company LLC, an investment adviser. This is a new filing by FMR; no prior 13G from this filer was found in the cross-filing context.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 667,465 shares of Gossamer Bio common stock as of October 30, 2026
- The stake represents 10.9% of shares outstanding
- Fidelity Management & Research Company LLC is the investment adviser with 5%+ ownership
- The filing certifies passive intent under Rule 13d-1(b)
- Select Biotechnology Portfolio held 667,460 shares (10.9%) of the total
- This is a new SC 13G filing by FMR LLC; no prior 13G from this filer was found in the cross-filing context
Financial Impact
10.9% stake valued at approximately $6.6 million based on $61M market cap
Risk Factors
- FMR's passive certification could change if it later engages with management or seeks board representation
- Micro-cap biotech with high volatility; large holder could influence stock via entry/exit
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000315066-26-002941 |
| Document: 0000315066-26-002941-index-headers.html | 0000315066-26-002941 |
| Document: 0000315066-26-002941-index.html | 0000315066-26-002941 |
| Document: 0000315066-26-002941.txt | 0000315066-26-002941 |
Track record
20 reports on GOSS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.28% at T+60 after the Jun 17, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today S-3 Neutral 3/10 Entry $10.98 Now $10.98 −0.00% settles Feb 16
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $11.69 Now $10.98 −6.07% settles Feb 9
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $10.65 Now $10.98 +3.15% settles Feb 5
- Nov 6, 202610d ago SC 13G Neutral 4/10 Viewing Entry $9.77 Now $10.98 +12.38% settles Feb 4
- Oct 29, 202618d ago SC 13D/A Bearish 5/10 Entry $10.38 Now $10.98 −5.78% settles Jan 28
- Oct 8, 20265w ago SC 13D/A Bearish 5/10 Entry $9.31 Now $10.98 −17.94% settles Jan 6
- Sep 28, 20267w ago SC 13D/A Bearish 6/10 Entry $11.58 Now $10.98 +5.18% settles Dec 23
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $11.69 Now $10.98 −6.07% settles Dec 16
- Sep 16, 20268w ago 8-K Neutral 4/10 Entry $11.94 Now $10.98 −8.04% settles Dec 11
- Sep 11, 20269w ago 8-K Bearish 6/10 Entry $10.73 Now $10.98 −2.33% settles Dec 7
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers